Belgium vs Iceland: Pharmaceutical consumption

Belgium
213 Defined daily dose per 1 000 inhabitants per day
in 2024
Iceland
236.8 Defined daily dose per 1 000 inhabitants per day
in 2025
Belgium rank
18th
Iceland rank
17th

Pharmaceutical consumption over time

  • Belgium
  • Iceland
50100150200250198920072025

How they compare

Iceland currently reports 236.8 Defined daily dose per 1 000 inhabitants per day against 213 Defined daily dose per 1 000 inhabitants per day in Belgium, a difference of 23.8 Defined daily dose per 1 000 inhabitants per day.

That makes Iceland's figure about 1.1 times Belgium's.

The two have swapped places 2 times across 28 shared years of data; in 1997 it was Iceland ahead.

Belgium ranks 18th and Iceland ranks 17th of 21 countries.

Across the 4 decades both report, Belgium averaged higher in 1 and Iceland in 3.

Head to head by decade

Decade Belgium Iceland Difference Ahead
1990s 60.87 Defined daily dose per 1 000 inhabitants per day 112.33 Defined daily dose per 1 000 inhabitants per day 51.47 Defined daily dose per 1 000 inhabitants per day Iceland
2000s 104.57 Defined daily dose per 1 000 inhabitants per day 114.12 Defined daily dose per 1 000 inhabitants per day 9.55 Defined daily dose per 1 000 inhabitants per day Iceland
2010s 173.91 Defined daily dose per 1 000 inhabitants per day 155.73 Defined daily dose per 1 000 inhabitants per day 18.18 Defined daily dose per 1 000 inhabitants per day Belgium
2020s 200.64 Defined daily dose per 1 000 inhabitants per day 208.98 Defined daily dose per 1 000 inhabitants per day 8.34 Defined daily dose per 1 000 inhabitants per day Iceland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pharmaceutical consumption, Belgium or Iceland?
Iceland, at 236.8 Defined daily dose per 1 000 inhabitants per day against 213 Defined daily dose per 1 000 inhabitants per day in Belgium as of 2025.
What is the difference in pharmaceutical consumption between Belgium and Iceland?
23.8 Defined daily dose per 1 000 inhabitants per day, with Iceland ahead.
How many years of comparable data are there for Belgium and Iceland?
28 years are reported by both, from 1997 to 2024.
How do Belgium and Iceland rank globally for pharmaceutical consumption?
Belgium ranks 18th and Iceland ranks 17th of 21 countries.
Where does this data come from?
Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Belgium vs Iceland: Pharmaceutical consumption. Statizoid, drawing on Organisation for Economic Co-operation and Development. Retrieved 20 August 2026, from https://health.statizoid.com/compare/pharmaceutical-consumption/belgium/iceland/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under OECD Terms and Conditions (attribution required); please keep the attribution.

<a href="https://health.statizoid.com/compare/pharmaceutical-consumption/belgium/iceland/">Belgium vs Iceland: Pharmaceutical consumption</a> — Statizoid

About this data

Indicator
Pharmaceutical consumption
Unit
Defined daily dose per 1 000 inhabitants per day
Source
Organisation for Economic Co-operation and Development
Licence
OECD Terms and Conditions (attribution required)
Coverage
31 places, 708 data points, 1980–2025
Last refreshed

Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.